NFE2L2 and metabolic dysfunction-associated steatotic liver disease: AMPK has been shown to prevent ferroptosis in conditions like diabetic cardiomyopathy (DCM), diabetic nephropathy (DN), NAFLD, and pulmonary fibrosis by promoting Nrf2 transcription or translation 83, 98, 99.